Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with stage II or III breast cancer (limited to a specific area, not spread widely) that is either HER2-positive or triple-negative, confirmed by a tissue sample (biopsy)
- Your medical team has agreed that chemotherapy before surgery (neoadjuvant chemotherapy) is the right treatment for you
- You are covered by a social security or health insurance scheme
- You have read and signed a consent form agreeing to take part in the study
Who may not be able to join:
- You have been identified as being at very high genetic risk of cancer, such as having a BRCA1 or BRCA2 gene mutation, Li-Fraumeni syndrome, Lynch syndrome, or having previously had radiation therapy to the chest area for lymphoma (confirm with trial site)
- You are currently pregnant or breastfeeding
- You have an allergy or sensitivity to the dye used in certain scans (iodinated contrast material), or your kidneys are not working well enough (a specific kidney function measurement is below a certain level)
- You do not speak or read French fluently
- You are legally considered a protected adult, meaning you are under a legal guardianship or curatorship arrangement
- You are currently taking part in another research study that requires a waiting period before joining a new one
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The evolution of the relative tumor enhancement (RTEe) (%) between the baseline and early re-evaluation CESM
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.